Adagene and Exelixis reach milestone in SAFEbody ADC collaboration
Adagene announced it achieved a milestone in its ongoing collaboration with Exelixis to advance SAFEbody antibody-drug conjugate candidates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.